tirzepatide ban update Is Legal in 2026? FDA Status, Compounding & TGA proposes ban on injectable

This analysis discusses findings from the 2025 KFF Employer Health Benefits Survey, with insights gained from interviews and group discussions with human resources directors and others who manage employer health benefits

Ongoing provider messaging, dosage adjustments, and medication changes are managed through the platform as part of the platform's support structure

* Correspondence: Li Yang [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

10.1161/JAHA.114.001075 92